Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable for Anti-Competitive Tactics That Keep Drug Prices High Washington, D.C. – On Tuesday, February 6 at 10:00 AM, Campaign for Sustainable Rx Pricing (CSRxP) executive director Lauren Aronson will participate in a panel discussion with U.S. Senators Peter Welch (D-VT) and Amy Klobuchar (D-MN) on […]
Brand Name Drug Companies’ Price Increases in First Two Weeks of 2024 Continue to Outpace the Rate of Inflation Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on a new report that found Big Pharma hiked prices on 775 brand name prescription drugs in the first two weeks of the […]
Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to Maintain Monopoly Pricing Power and End-Run Solutions Meant to Discourage Price Increases Above the Rate of Inflation Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on GSK’s strategy to discontinue the brand name inhaler Flovent and replace the product […]
Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to Start the New Year Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on reports that brand name drug companies plan to hike prices on at least 500 prescription drugs to start the year, as part of the pharmaceutical industry’s traditional biennial […]
Administration Announces Drug Makers Increased Prices Faster Than Rate of Inflation on 48 Medicare Part B Drugs in Final Quarter of 2023 Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday after the Biden-Harris Administration announced that Big Pharma companies increased prices faster than the rate of inflation on 48 Medicare Part […]
Pfizer and Moderna Raise Prices on Vaccines After Years of Taxpayer Investments Fueling Revenue for the Brand Name Drug Companies Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to brand name drug makers officially setting the list price of their COVID vaccines between $120 and $130 as payment shifts […]
Analysis Finds Brand Name Drug Makers Setting U.S. Prices for Obesity Medications More Than Five Times Higher Than Prices for Other Countries Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday reacting to a new analysis from the Peterson-KFF Health System Tracker analyzing the price of several new weight loss drugs in […]
Americans from Across the Political Spectrum Want Congress to Pass Bipartisan Legislation to Crack Down on Big Pharma’s Abuse of the Patent System and Boost List Price Transparency Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey today. The bipartisan survey was jointly conducted by two industry leading […]
Over 15 Year Period, Brand Name Drug Companies Increasingly Filed for “Secondary” Patents Compared to Original Patents for New Drugs Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday reacting to a new analysis published in The Journal of American Medical Association (JAMA) examining the number of “secondary” patent filings brand name […]
Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to Price-Gouging Patients Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a new round of price hikes from Big Pharma to start the month of July, as part of traditional biannual increases from the pharmaceutical industry. According to data from […]